NYSE$CI

Cigna Group · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Briefing

The Cigna Group reported Q1 2026 total revenues of $68.5B, shareholders' net income of $1.7B ($6.26 EPS), and raised 2026 adjusted EPS outlook to at least $30.35.

Total revenues rose 5% to $68.5 billion. Shareholders' net income was $1.7 billion, or $6.26 per share, versus $1.3 billion and $4.85 a year ago. Adjusted income from operations was $2.1 billion, or $7.79 per share, up from $1.8 billion and $6.74. Management raised full-year 2026 adjusted EPS guidance to at least $30.35 per share on disciplined execution across Evernorth and U.S. Healthcare.

  • Total revenues $68.5B (+5% YoY).
  • Shareholders' net income $1.7B; diluted EPS $6.26.
  • Adjusted income from operations $2.1B; adjusted EPS $7.79.
  • 2026 adjusted EPS outlook raised to at least $30.35.
  • Growth across diversified health services and pharmacy benefits.

Headline financials

Total Revenue

$72.5B

Previous: $65.7B+10.3%
EPS (adj)

$7.79

Previous: $6.64+17.3%
Adjusted EPS

$8.08

Previous: $6.64+21.7%
SG&A Expense Ratio

5.0%

Previous: 5.9%-15.3%
Adj. SG&A Ratio

4.7%

Previous: 5.7%-17.5%
Medical Care Ratio

88.0%

Previous: 87.9%+0.1%
Total Customer Relationships

188.4M

Previous: 182.2M+3.4%
Pharmacy Customers

123.6M

Previous: 118.3M+4.5%
Medical Customers

18.1M

Previous: 19.1M-5.4%
Net Income

$1.23B

Previous: $1.42B-13.3%
Operating Income

$2.15B

Previous: $1.85B+16.4%

Revenue & EPS history

Cigna · Revenue · Quarterly

$72.5B

Q4 2025+10.3%vs Q4 2024
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

Management raised 2026 consolidated adjusted income from operations to at least $30.35 per share while highlighting portfolio shaping and innovation investments.

Tailwinds

  • Raised full-year adjusted EPS outlook.
  • Double-digit growth in key Evernorth and healthcare segments.

Headwinds

  • Medical cost trend and regulatory policy remain key variables.
  • Integration and litigation items can affect GAAP vs. adjusted results.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-0.9%

Avg return

Earnings day

-1.1%

Avg return

5 days after

-0.4%

Avg return

30 days after

48%

31 / 65 earnings

Positive

+8.6%

Q1 2023

Best reaction

-17.4%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-5.7%-5.2%
Q4 2025-0.6%-5.7%-5.2%
Q3 2025-17.4%-11.5%-7.3%
Q2 2025-10.2%-9.1%+1.0%
Q1 2025-0.5%-0.2%-5.5%
Q4 2024-6.7%-3.9%+1.8%
Q3 2024+1.2%+1.8%+8.0%
Q2 2024-3.3%-5.6%+3.8%
Q1 2024-4.4%-2.9%-3.5%
Q4 2023+4.5%+7.6%+8.3%
Q3 2023+0.4%-4.6%-13.1%
Q2 2023-4.3%-2.4%-7.6%
Q1 2023+8.6%+8.1%+5.5%
Q4 2022-4.3%-3.8%-4.8%
Q3 2022+0.4%+2.1%+2.0%
Q2 2022+3.7%+4.9%+5.9%
Q1 2022+4.4%+1.9%-0.7%
Q4 2021-3.8%+0.8%+5.0%
Q3 2021-1.9%-0.9%-8.4%
Q2 2021-9.6%-8.9%-6.3%
Q1 2021+3.9%+0.7%-1.6%
Q4 2020-7.3%-3.8%+5.1%
Q3 2020-4.3%+4.5%+3.3%
Q2 2020-5.0%-4.6%-0.4%
Q1 2020-4.5%-2.8%+0.7%
Q4 2019+1.2%+4.2%-5.3%
Q3 2019+1.7%+3.1%+13.3%
Q2 2019-3.1%-3.6%-9.4%
Q1 2019-5.7%-4.2%-8.6%
Q4 2018-3.9%-6.2%-10.8%
Q3 2018-0.3%+0.2%+4.5%
Q2 2018+3.5%+2.9%+3.0%
Q1 2018-0.7%-1.0%-0.9%
Q4 2017-1.9%-5.2%-7.3%
Q3 2017+2.1%+3.9%+5.3%
Q2 2017-0.0%+1.2%+4.0%
Q1 2017+3.2%+3.9%+4.9%
Q4 2016+1.1%+0.2%+2.9%
Q3 2016+3.2%+9.3%+13.2%
Q2 2016-6.8%-8.4%-6.1%
Q1 2016-2.6%
Q4 2015+0.4%
Q3 2015+0.4%
Q2 2015-0.9%
Q1 2015-0.9%
Q4 2014+1.5%
Q3 2014+5.9%
Q2 2014-2.9%
Q1 2014+3.3%
Q4 2013-10.1%
Q3 2013+5.0%
Q2 2013-0.7%
Q1 2013+2.7%
Q4 2012+3.8%
Q3 2012+4.1%
Q2 2012+4.6%
Q1 2012-2.8%
Q4 2011+2.9%
Q3 2011-6.0%
Q2 2011+1.8%
Q1 2011+2.4%
Q4 2010+4.3%
Q3 2010+2.0%
Q2 2010-6.3%
Q1 2010+1.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro